Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
2.830
-0.110 (-3.74%)
Mar 30, 2026, 10:05 AM EDT - Market open
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.49 billion as of March 30, 2026. Its market cap has decreased by -37.44% in one year.
Market Cap
1.49B
Enterprise Value
887.59M
1-Year Change
-37.44%
Ranking
Category
Stock Price
$2.83
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $1.49B, a decrease of -70.55%. That is a compound annual growth rate of -21.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.55B | -27.05% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocular Therapeutix | 1.64B |
| Sionna Therapeutics | 1.63B |
| Soleno Therapeutics | 1.55B |
| Damora Therapeutics | 1.54B |
| Harmony Biosciences Holdings | 1.54B |
| Nurix Therapeutics | 1.53B |
| Maze Therapeutics | 1.51B |
| Palvella Therapeutics | 1.51B |